Next Article in Journal
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients
Previous Article in Journal
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
Previous Article in Special Issue
Attitude to Co-Administration of Influenza and COVID-19 Vaccines among Pregnant Women Exploring the Health Action Process Approach Model
 
 
Review

Article Versions Notes

Vaccines 2024, 12(8), 847; https://doi.org/10.3390/vaccines12080847 (registering DOI)
Action Date Notes Link
article xml file uploaded 28 July 2024 10:17 CEST Original file -
article xml uploaded. 28 July 2024 10:17 CEST Update https://www.mdpi.com/2076-393X/12/8/847/xml
article pdf uploaded. 28 July 2024 10:17 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/847/pdf
article html file updated 28 July 2024 10:20 CEST Original file https://www.mdpi.com/2076-393X/12/8/847/html
Back to TopTop